Industry News

Oct 01, 2018
FDA is joining with other federal health agencies and the biomedical research community to advance the science, regulatory policies, and reimbursement strategies to support innovation in antimicrobials.
Oct 01, 2018
By BioPharm International Editors
Researchers who are younger than 35 years with an advanced degree and working within Europe will be able to apply for the award.
Sep 28, 2018
By BioPharm International Editors
The agency sent a warning letter to the Indian company after an inspection found CGMP violations that included a lack of written procedures and analytical testing.
Sep 28, 2018
By BioPharm International Editors
CPhI releases the bio trends portion of its annual report, which predicts an increase in bioconjucation expertise and biopharma productivity over the next five years.
Sep 27, 2018
By BioPharm International Editors
The agency has entered into an agreement with the National Academies of Science, Engineering & Medicine and has expanded agreements with the University of Maryland and Johns Hopkins University Centers for Regulatory Science and Innovation to conduct research on the compounding of drugs.
Sep 27, 2018
By BioPharm International Editors
The agency announced that differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors.
Sep 27, 2018
By BioPharm International Editors
The European Medicines Agency revised the number of centrally authorized medicines for which there are concerns over Brexit-related supply disruptions.
Sep 26, 2018
By BioPharm International Editors
The National Institute for Health and Care Excellence recently rejected National Health Service’s funding of Kymriah for diffuse large B-cell lymphoma (DLBCL) despite recognizing that the drug has significant clinical benefits.
Sep 25, 2018
By BioPharm International Editors
Winners for each category will be revealed at the CPhI Pharma Awards Gala, taking place on Oct. 9, 2018.
Sep 24, 2018
By BioPharm International Editors
FDA awarded nearly $3 million in grants for continuous manufacturing and other advanced manufacturing technologies as part of the agency’s efforts to ensure a robust and reliable supply of biological products.
native1_300x100
lorem ipsum